Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2006

Mar 13, 2006

30339_dirs_2006-03-13_fe919464-9a89-4521-b0d8-0b99300ae558.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2006-02-24

Reporting Person: FEDERICI WILLIAM J (VP & CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2006-02-24 Common Stock A 6557 Acquired 30620.0014 Direct
2006-02-24 Common Stock A 1844.3491 $32.5850 Acquired 32464.3505 Direct
2006-02-24 Common Stock A 1600 Acquired 34064.3505 Direct
2006-02-24 Common Stock A 12.95 $32.7800 Acquired 8200.1412 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2006-02-24 Stock Option (Right to Buy) $32.5850 A 19183 Acquired 2016-02-24 Common Stock (19183.00) Direct

Footnotes

F1: Bonus and incentive shares granted on 2/24/06.

F2: Additional amount of shares due to achieving above targeted amount for first performance period of 3/7/05 Performance Vested Restricted Share grant.

F3: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.

F4: Amount in error as the incorrect price was used to calculate the number of shares.